We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bespak | LSE:BPK | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 667.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/11/2002 08:24 | BPK - 3 main reasons these should continue to have problems: 1. Weston Medical syringe delays...nuff said on that thread already. 2. Inhale Therapeutics - inhaled insulin - which quite frankly, will be years before its accepted by the medical establishment as dosing depends on patients lung tissue and health - not an issue with injected dosing. 3 - this is the biggy - delays with CFC devices in the US. There is much anecdotal evidence that prevalence of asthma is plateauing as the general health of the Western world improves - customers have over-ordered and quite clearly are having difficulty shifting stock. Also - with the pressure on the pharma industry in general to cut costs, the development of new fancy inhaler devices will be questioned closely. For some reason there now seems to be a lot of emphasis on nasal drug delivery for this company. This is an even more unpredicatable way to deliver drugs with such a variable dose absorption depending on the state of people's nasal mucosa. They should have stuck to the knitting. | cat | |
18/7/2002 12:17 | Check out NWD for a quick profit. MMs obviously short of stock, worth buying a few for a quick 20% gain. | market_leader 2002 | |
06/4/2002 11:33 | * Medical devices company Bespak’s (BPK) non-executive director William Meredith has been shopping on the other side of the Atlantic as he picked up 5,000 American Depository Receipts on Wednesday at $7.50 (523p). His £26,130 payout doubles his holding in the company to 10,000 ADRs. Meredith has pounced while Bespak’s share price is struggling close to its year-low. It began the year in sprightly fashion at a high of 590p but fell gradually until it hit 500p last week. After a brief rally it has stalled and today closed down 1p at 504p. In January the company reported record sales in the six months to 2 November of £42.9 million, up from £40.4 million the previous year. However pre-tax profits slipped from £7.8 million to £7.2 million after higher research and development costs. | daycase1 | |
28/2/2002 11:25 | well i dont follow but i do have cash invested ( £1.20 ) | cleverboy | |
13/11/2001 01:54 | Anyone follow this dog? | sham3001 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions